Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

On 28th of April, The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA) have published version 3 of their guidance to sponsors on how to manage clinical trials during the COVID-19 (Coronavirus) pandemic.

Key changes from v2 (27-03-2020): distributor to trial participant IMP shipment, monitoring, remote source data verification and communication with authorities

https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-10/guidanceclinicaltrials_covid19_en.pdf

Need more information ?

BECRO

PLACE MARCEL BROODTHAERS PLEIN, 8 BOX 5
B-1060 BRUSSELS / BELGIUM
PHONE: +32 (0)2 892 40 00
E-MAIL: INFO@BECRO.BE

© 2018 BECRO – ALL RIGHTS RESERVED

Octopix + WordPress = ♥ | Design by Simplexity